Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Change in Account Payables: 2013-2020

Historic Change in Account Payables for Larimar Therapeutics (LRMR) over the last 7 years, with Dec 2020 value amounting to $905,000.

  • Larimar Therapeutics' Change in Account Payables rose 112.44% to $905,000 in Q4 2020 from the same period last year, while for Dec 2020 it was -$3.3 million, marking a year-over-year decrease of 225.02%. This contributed to the annual value of $1.1 million for FY2024, which is 383.13% up from last year.
  • As of Q4 2020, Larimar Therapeutics' Change in Account Payables stood at $905,000, which was up 199.56% from -$909,000 recorded in Q3 2020.
  • Larimar Therapeutics' Change in Account Payables' 5-year high stood at $2.5 million during Q2 2017, with a 5-year trough of -$4.1 million in Q1 2016.
  • For the 3-year period, Larimar Therapeutics' Change in Account Payables averaged around -$18,833, with its median value being $89,500 (2018).
  • In the last 5 years, Larimar Therapeutics' Change in Account Payables surged by 766.47% in 2016 and then slumped by 467.19% in 2020.
  • Larimar Therapeutics' Change in Account Payables (Quarterly) stood at -$1.1 million in 2016, then soared by 132.21% to $344,000 in 2017, then surged by 140.99% to $829,000 in 2018, then plummeted by 48.61% to $426,000 in 2019, then skyrocketed by 112.44% to $905,000 in 2020.
  • Its Change in Account Payables was $905,000 in Q4 2020, compared to -$909,000 in Q3 2020 and -$760,000 in Q2 2020.